V.A. cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics

Medicine and Dentistry

• Diabetes Mellitus 100%
• Amputation 100%
• Gangrene 100%
• Antiplatelet Drug 100%
• Patient 100%
• Vascular Disease 37%
• Cerebrovascular Disease 25%
• Myocardial Infarction 25%
• Group Therapy 25%
• Apoplexy 25%
• Retinopathy 25%
• Man 25%
• Hypertension 12%
• Combination Therapy 12%
• Smoking 12%
• Patient Population 12%
• Diabetes 12%
• Insulin 12%
• Transient Ischemic Attack 12%
• Renal Failure 12%
• Dipyridamole 12%
• Antiplatelet 12%
• Congestive Heart Failure 12%
• Acetylsalicylic Acid 12%
• Age 12%
• Sensory Neuropathy 12%
• Diet 12%
• Veteran 12%
• Death 12%
• Angina pectoris 12%

INIS

• design 100%
• patients 100%
• cooperatives 100%
• gangrene 100%
• vascular diseases 33%
• data 22%
• risks 22%
• diseases 22%
• men 22%
• myocardial infarction 22%
• tid 22%
• therapy 11%
• information 11%
• medical centers 11%
• populations 11%
• administration 11%
• kidneys 11%
• failures 11%
• hypertension 11%
• death 11%
• ischemia 11%
• insulin 11%
• weight 11%
• doses 11%
• diet 11%
• heart failure 11%
• aspirin 11%
• dipyridamole 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Diabetes Mellitus 100%
• Gangrene 100%
• Antithrombocytic Agent 100%
• Vascular Disease 50%
• Heart Infarction 33%
• Cerebrovascular Disease 33%
• Retinopathy 33%
• Insulin 16%
• Hypertension 16%
• Congestive Heart Failure 16%
• Acetylsalicylic Acid 16%
• Anticoagulant Agent 16%
• Kidney Failure 16%
• Transient Ischemic Attack 16%
• Sensory Neuropathy 16%
• Angina Pectoris 16%
• Death 16%
• Dipyridamole 16%
• Placebo 16%